DMPK and myotonic dystrophy type 1: In DM1, toxic DMPK RNAs with CUG expansion induce a sequestration and inhibition of the RNA-binding protein MBNL1 that contributes to aberrant splicing providing an explanation for many of the symptoms observed in DM1 patients [62,118,119].